Document Detail


Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
MedLine Citation:
PMID:  20378385     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Visceral leishmaniasis is a protozoan infection usually asymptomatic, but can progress to fatal disease in immunocompromised hosts, especially in HIV patients. Visceral leishmaniasis is rare among patients under immunosuppressive therapies, and even more among patients under anti-TNF-alpha treatment, where only four cases have been described. OBJECTIVE: 1) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, pancytopenia, splenomegaly, and extreme hyperferritinemia. 2) To perform a review of the published cases of visceral leishmaniasis and anti-TNF-alpha therapy, and cases of coexisting leishmaniasis and macrophagic activation syndrome by search in PubMed (period 1991-2008). RESULTS: Visceral leishmaniasis was established by bone marrow aspiration, and although there was no histological confirmation, according to HLH-2004 criteria, a secondary macrophagic activation syndrome was established. The patient had a favourable outcome. CONCLUSION: We report herein the fifth case of visceral leishmaniasis in a patient under TNF-alpha therapy, and the first one, to our knowledge, presenting a consequent secondary macrophagic activation syndrome.
Authors:
Anna Moltó; Lourdes Mateo; Natalia Lloveras; Alejandro Olivé; Sonia Minguez
Related Documents :
8331355 - Paroxysmal alien hand syndrome.
9286155 - Classification of sneddon's syndrome.
9548305 - Endoscopic manometry of the sphincter of oddi in patients with lemmel's syndrome.
21345085 - Pre-term diagnosis of choristoma and choroidal coloboma in goldenhar's syndrome.
16149825 - Hypoplasia and hypodontia in van der woude syndrome.
1110205 - Superior oblique tendon sheath syndrome of brown.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-04-07
Journal Detail:
Title:  Joint, bone, spine : revue du rhumatisme     Volume:  77     ISSN:  1778-7254     ISO Abbreviation:  Joint Bone Spine     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-25     Completed Date:  2010-08-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100938016     Medline TA:  Joint Bone Spine     Country:  France    
Other Details:
Languages:  eng     Pagination:  271-3     Citation Subset:  IM    
Copyright Information:
Copyright 2010. Published by Elsevier SAS.
Affiliation:
Rheumatology Section, Hospital Universitari Germans Trias I Pujol, Ctra del Canyet s/n, 08916 Badalona, Spain. anmoltre@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / administration & dosage,  adverse effects*
Antirheumatic Agents / administration & dosage*
Arthritis, Rheumatoid / complications,  drug therapy*,  immunology
Humans
Immunocompromised Host
Leishmaniasis, Visceral / complications,  immunology*
Macrophage Activation Syndrome / complications,  immunology*
Male
Middle Aged
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antirheumatic Agents; 0/Tumor Necrosis Factor-alpha; 0/adalimumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there a link between inflammation and abnormal lipoprotein profile in Sj??gren's syndrome?
Next Document:  Cerebral palsy and perinatal asphyxia (I- Diagnosis).